(Q41927034)

14 October 2017

Interaction of cyclosporin derivatives with the ATPase activity of human P-glycoprotein (English)

1 reference

14 October 2017

T Watanabe

1

1 reference

14 October 2017

N Kokubu

2

1 reference

14 October 2017

S B Charnick

3

1 reference

14 October 2017

M Naito

4

1 reference

14 October 2017

T Tsuruo

5

1 reference

14 October 2017

D Cohen

6

1 reference

14 October 2017

language of work or name

English

0 references

publication date

1 September 1997

1 reference

British Journal of Pharmacology

14 October 2017

1 reference

14 October 2017

122

1 reference

14 October 2017

2

1 reference

14 October 2017

241-248

1 reference

Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system

14 October 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

Mechanisms of multidrug resistance and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

Modulation of multidrug resistance by SDZ PSC 833 in leukemic and solid-tumor-bearing mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

A pharmacokinetic analysis program (multi) for microcomputer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

7 January 2021

Restoration of daunomycin retention in multidrug-resistant P388 cells by submicromolar concentrations of SDZ PSC 833, a nonimmunosuppressive cyclosporin derivative

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

7 January 2021

An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

7 January 2021

Absence of cooperativity for MgATP and verapamil effects on the ATPase activity of P-glycoprotein containing membrane vesicles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

7 January 2021

Modulation of ATP and drug binding by monoclonal antibodies against P-glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

7 January 2021

Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

7 January 2021

Biochemistry of multidrug resistance mediated by the multidrug transporter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

7 January 2021

Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

7 January 2021

Modulation of human P-glycoprotein epitope expression by temperature and/or resistance-modulating agents.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

7 January 2021

Structurally distinct MDR modulators show specific patterns of reversal against P-glycoproteins bearing unique mutations at serine939/941.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

7 January 2021

Functional analysis of P-glycoprotein mutants identifies predicted transmembrane domain 11 as a putative drug binding site.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

7 January 2021

Functional modulation of ATPase of P-glycoprotein by C219, a monoclonal antibody against P-glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

7 January 2021

Circumvention of P-GP MDR as a function of anthracycline lipophilicity and charge

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

7 January 2021

Mutations to amino acids located in predicted transmembrane segment 6 (TM6) modulate the activity and substrate specificity of human P-glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

7 January 2021

Inhibition of Oxidative Cross-linking between Engineered Cysteine Residues at Positions 332 in Predicted Transmembrane Segments (TM) 6 and 975 in Predicted TM12 of Human P-glycoprotein by Drug Substrates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

7 January 2021

Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16 and synergistic modulation of multidrug resistance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

7 January 2021

Potentiation of the reversal activity of SDZ PSC833 on multi-drug resistance by an anti-P-glycoprotein monoclonal antibody MRK-16

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

7 January 2021

Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185----Val-185 substitution in P-glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

7 January 2021

Interaction of bioactive hydrophobic peptides with the human multidrug transporter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

7 January 2021

Interaction of the P-glycoprotein multidrug transporter with peptides and ionophores

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

7 January 2021

Transport of cyclosporin A across the brain capillary endothelial cell monolayer by P-glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701377

7 January 2021

Identifiers

DOI

10.1038/SJ.BJP.0701377

1 reference

14 October 2017

1 reference

14 October 2017

1 reference